Gabapentin: an alternative to the cyclooxygenase-2 inhibitors for perioperative pain management
- PMID: 16368826
- DOI: 10.1213/01.ane.0000184824.43411.63
Gabapentin: an alternative to the cyclooxygenase-2 inhibitors for perioperative pain management
Abstract
The cyclooxygenase-2 inhibitor, rofecoxib, was a popular analgesic adjuvant for improving perioperative pain management. We designed this placebo-controlled study to test the hypothesis that gabapentin could produce similar reductions in postoperative pain and opioid analgesic usage, thereby improving the recovery process. One hundred patients undergoing abdominal hysterectomy procedures were randomly assigned to one of four treatment groups: 1) control group received placebo capsules and pills before and for 2 days after surgery, 2) rofecoxib group received 50 mg/d PO and placebo capsules before and after surgery and, 3) gabapentin group received 1.2 g/d PO and placebo pills before and after surgery, and 4) combination group received rofecoxib 50 mg/d and gabapentin 1.2 g/d PO before and after surgery. The anesthetic technique was standardized and the postoperative assessments included verbal rating scales for pain and sedation, IV morphine usage, quality of recovery assessment, recovery of bowel function, resumption of normal activities, and patient satisfaction with their pain management. Postoperative pain scores were significantly reduced in all three analgesic treatment groups (versus control group). Compared with the control group, patient-controlled analgesia morphine usage was also significantly reduced in the 3 analgesic treatment groups at 1, 8, 24, and 30 h after surgery. Total PCA morphine usage was decreased by 43%, 24%, and 50% in groups 2, 3, and 4, respectively, compared with group 1. Oral analgesic consumption was also smaller in groups 2 and 4 when compared with the control group. The opioid-sparing effects of rofecoxib and gabapentin lead to a faster recovery of bowel function. Discharge eligibility scores in groups 2 and 4 were improved at 24 h when compared with group 1, and patient satisfaction with postoperative pain management was significantly higher at 24 h in all 3 analgesic treatment groups. At the 72 h follow-up, all of the patients in group 4 were completely satisfied with their pain management compared with only 32%, 64%, and 72% in groups 1, 2, and 3, respectively. Gabapentin (1.2 g/d PO) appears to be an acceptable alternative to rofecoxib (50 mg/d PO) for short-term use as an adjuvant to opioid analgesics in patients undergoing lower abdominal surgery.
Similar articles
-
Is gabapentin effective and safe in open hysterectomy? A PRISMA compliant meta-analysis of randomized controlled trials.J Clin Anesth. 2017 Sep;41:76-83. doi: 10.1016/j.jclinane.2017.07.002. Epub 2017 Jul 18. J Clin Anesth. 2017. PMID: 28802618 Review.
-
Gabapentin for Perioperative Analgesia in Otorhinolaryngology-Head and Neck Surgery: Systematic Review.Otolaryngol Head Neck Surg. 2016 Dec;155(6):893-903. doi: 10.1177/0194599816659042. Epub 2016 Jul 26. Otolaryngol Head Neck Surg. 2016. PMID: 27459955 Review.
-
The effects of gabapentin on acute and chronic postoperative pain after coronary artery bypass graft surgery.J Cardiothorac Vasc Anesth. 2011 Oct;25(5):824-9. doi: 10.1053/j.jvca.2010.11.017. Epub 2011 Jan 12. J Cardiothorac Vasc Anesth. 2011. PMID: 21232979 Clinical Trial.
-
A comparison of gabapentin and ketamine in acute and chronic pain after hysterectomy.Anesth Analg. 2009 Nov;109(5):1645-50. doi: 10.1213/ANE.0b013e3181b65ea0. Anesth Analg. 2009. PMID: 19843803 Clinical Trial.
-
Efficacy of oral rofecoxib versus intravenous ketoprofen as an adjuvant to PCA morphine after urologic surgery.Acta Anaesthesiol Scand. 2004 Oct;48(9):1190-3. doi: 10.1111/j.1399-6576.2004.00496.x. Acta Anaesthesiol Scand. 2004. PMID: 15352968 Clinical Trial.
Cited by
-
Dose-related beneficial and harmful effects of gabapentin in postoperative pain management - post hoc analyses from a systematic review with meta-analyses and trial sequential analyses.J Pain Res. 2017 Nov 1;10:2547-2563. doi: 10.2147/JPR.S138519. eCollection 2017. J Pain Res. 2017. PMID: 29138592 Free PMC article. Review.
-
Gabapentin in procedure-specific postoperative pain management - preplanned subgroup analyses from a systematic review with meta-analyses and trial sequential analyses.BMC Anesthesiol. 2017 Jun 21;17(1):85. doi: 10.1186/s12871-017-0373-8. BMC Anesthesiol. 2017. PMID: 28637424 Free PMC article. Review.
-
A Review of Adjunctive CNS Medications Used for the Treatment of Post-Surgical Pain.CNS Drugs. 2017 Jul;31(7):605-615. doi: 10.1007/s40263-017-0440-1. CNS Drugs. 2017. PMID: 28577135 Review.
-
Analysis of opioid consumption in clinical trials: a simulation based analysis of power of four approaches.J Pharmacokinet Pharmacodyn. 2017 Aug;44(4):325-333. doi: 10.1007/s10928-017-9522-4. Epub 2017 Apr 7. J Pharmacokinet Pharmacodyn. 2017. PMID: 28389762
-
Analgesic effects of gabapentin and diclofenac on post-operative pain in patients undergoing tonsillectomy.Arch Trauma Res. 2014 Aug 26;3(3):e11443. doi: 10.5812/atr.11443. eCollection 2014 Sep. Arch Trauma Res. 2014. PMID: 25593895 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials